Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
29.35
+0.82 (2.87%)
Apr 8, 2026, 4:00 PM EDT - Market closed
Assembly Biosciences Stock Forecast
Stock Price Forecast
The 5 analysts that cover Assembly Biosciences stock have a consensus rating of "Strong Buy" and an average price target of $44.2, which forecasts a 50.60% increase in the stock price over the next year. The lowest target is $38 and the highest is $50.
Price Target: $44.2 (+50.60%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Assembly Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Maintains $39 → $43 | Strong Buy | Maintains | $39 → $43 | +46.51% | Apr 6, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +70.36% | Mar 26, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +70.36% | Dec 22, 2025 |
| Mizuho | Mizuho | Buy Maintains $29 → $40 | Buy | Maintains | $29 → $40 | +36.29% | Nov 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +70.36% | Oct 14, 2025 |
Financial Forecast
Revenue This Year
15.71M
from 72.30M
Decreased by -78.27%
Revenue Next Year
52.72M
from 15.71M
Increased by 235.63%
EPS This Year
-3.55
from -0.55
EPS Next Year
2.02
from -3.55
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 33.8M | 137.8M | |||
| Avg | 15.7M | 52.7M | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -53.2% | 777.3% | |||
| Avg | -78.3% | 235.6% | |||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -2.43 | 2.65 | |||
| Avg | -3.55 | 2.02 | |||
| Low | -5.53 | 1.41 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.